Aditxt, Inc. Allowance for Doubtful Accounts, Premiums and Other Receivables
Aditxt, Inc. (ADTX) had Allowance for Doubtful Accounts, Premiums and Other Receivables of $0 as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables · last filed 2023-08-14
- 2023-06-30: Allowance for Doubtful Accounts, Premiums and Other Receivables $0.00.
- 2023-03-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $0.00.
- 2022-12-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $18.63K.
- 2022-09-30: Allowance for Doubtful Accounts, Premiums and Other Receivables $49.23K.
| Period end | Allowance for Doubtful Accounts, Premiums and Other Receivables |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $18.63K 10-Q · filed 2023-08-14 |
| 2022-09-30 | $49.23K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $50.81K 10-Q · filed 2022-08-15 |
| 2021-12-31 | $0.00 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |